GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) explored the circulating plasma microRNA (
miR)-181b,
miR-223,
miR-155, and
miR-145 as new potential
LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) the effect of ASB16-AS1 on CC via regulating
miR-1305. Methods: Differentially expressed lncRNAs associated
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) potential mechanism. Cardiac-specific microRNA-1 (
miR-1) transgenic (TG) and myocardial infarction (MI
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) of the analysis, no statistically significant changes in the expression level were found, although
miR-21 and
miR